Company / Net Debt per Share
Pacira BioSciences, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$4.62
FY2025
5-year range
$4.62 / $13.08
FY2021-FY2025
Trend
-30.8%
vs FY2024
Sector context
#27 of 82
Health Care
What the data says
At $4.62, Pacira BioSciences, Inc.'s net debt per share ranks #56 of 82 in the Health Care sector. Net Debt per Share has declined for 3 consecutive years, from $13.08 in FY2022 to $4.62 in FY2025.
Based on SEC 10-K filings.
4.62 in FY2025 with a 3-year CAGR of -29.3%.
Improved from $8.04 to $4.62 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -29.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 82 in Health CareTop 67% of 82This company $4.62 Sector average $1.13
▼
+308.8% above sector average
Key checks
Key Insights
- Pacira BioSciences, Inc.'s net debt per share has declined for 3 consecutive years.
- In FY2025, net debt per share decreased 30.8% year-over-year.
- Ranks #27 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.62 | -30.8% |
| FY2024 | $6.67 | -17.0% |
| FY2023 | $8.04 | -38.6% |
| FY2022 | $13.08 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $1.98 | +51.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026